Economic Evaluations in the Canadian Common Drug Review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference9 articles.
1. Beyond Fast Track for Drug Approvals
2. A Proposal for Radical Changes in the Drug-Approval Process
3. Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials
4. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors
5. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A systematic review of moral reasons on orphan drug reimbursement;Orphanet Journal of Rare Diseases;2021-06-30
2. Cause-effect chains in S-LCA based on DPSIR framework using Markov healthcare model: an application to “working hours” in Canada;The International Journal of Life Cycle Assessment;2021-03-30
3. Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer;The Pharmacogenomics Journal;2019-05-27
4. Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List;BMC Health Services Research;2019-02-11
5. Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary;The Pharmacogenomics Journal;2016-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3